EPISODE · Apr 25, 2026 · 1 MIN
Amex: Safe Bet, Zimmer & Charles River: Avoid
from The Daily News Now! Business
American Express shines as a long-term investment in the S&P 500, boasting 16% annual revenue growth and strong management. Meanwhile, Zimmer Biomet and Charles River Laboratories face challenges, with slowing growth and declining returns on capital, making them risky plays to avoid. Support the show:Get a discount at https://solipillow.com/discount/dnn. Advertise on DNN:[email protected] This is an automated, high-level news summary based on public reporting.Report issues to [email protected]. View sources & latest updates:https://sources.thednn.ai/fd58b60c4c5c16b8
NOW PLAYING
Amex: Safe Bet, Zimmer & Charles River: Avoid
No transcript for this episode yet
Similar Episodes
Mar 26, 2026 ·1m
Mar 19, 2026 ·34m
Feb 18, 2026 ·11m
Feb 11, 2026 ·45m